Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ONCY

ONCY News

Newswire

02:19

Oncolytics Biotech Secures FDA Approval for Phase 3 Pelareorep Study in Metastatic Pancreatic Ductal Adenocarcinoma

13:12

Oncolytics Biotech Rating Upgrade: A Positive Trend for the Company's Earnings Outlook

09:51

Precision Oncology Sector Sees Transformation with Biomarker-Driven Therapies and Immunotherapies.

09:24

Oncolytics Biotech Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer

07:32

Oncolytics Biotech: HC Wainwright Raises Buy Rating to $10, PT Elevated to $5

View More

About ONCY

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More